🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
COVID-19 is a disease with high rate of morbidity if symptomatic. There is ...
Status
Terminated
Location
Anders Bjartell
Start Date
2020-07-15
Trial ID
NCT04475601
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of enzalutam...
Status
Completed
Location
Urological Associates of Southern Arizona, PC
Start Date
2013-10-31
Trial ID
NCT02003924
Treatments Being Tested
The purpose of this study is to assess enzalutamide plus leuprolide in pati...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2014-12-17
Trial ID
NCT02319837
Treatments Being Tested
This phase Ib/II trial studies the safety, side effects, best dose, and eff...
Status
Terminated
Location
University of Michigan Comprehensive Cancer Center
Start Date
2015-12-01
Trial ID
NCT02555189
This is a Phase II, open-label, 2-arm, multicenter, international study des...
Status
Terminated
Location
The Oncology Institute of Hope & Innovation
Start Date
2022-11-17
Trial ID
NCT05588609
Treatments Being Tested
The purpose of this study is to determine if continued treatment with Enzal...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2013-10-22
Trial ID
NCT01995513
Treatments Being Tested
This research is being done to determine if receiving the combination of te...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2025-08-19
Trial ID
NCT06922318
The purpose of this study is to determine if enzalutamide given in combinat...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2013-12-16
Trial ID
NCT02007512
Treatments Being Tested